Related Experiment Video
Updated: Oct 2, 2025

Author Spotlight: Developing a Bedside Protocol for Kidney and Genitourinary Ultrasonography
Published on: June 21, 2024
Early Renal Ultrasound in Patients with Congenital Solitary Kidney Can Guide Follow-Up Strategy Reducing Costs While
Stefano Guarino1, Anna Di Sessa1, Simona Riccio1
1Department of Woman, Child and of General and Specialized Surgery, Università degli Studi della Campania "Luigi Vanvitelli", Via Luigi De Crecchio 2, 80138 Naples, Italy.
Insights
Renal length (RL) over 2 standard deviation scores (SDS) on early renal ultrasound (RUS) in infants with congenital solitary functioning kidney (CSFK) predicts a good prognosis, avoiding future kidney injury (KI). This approach reduces follow-up costs significantly.
Area of Science:
- Pediatric Nephrology
- Medical Imaging
- Health Economics
Background:
- Congenital solitary functioning kidney (CSFK) requires long-term monitoring for kidney injury (KI).
- Current follow-up protocols may be resource-intensive.
- Predictive markers for long-term outcomes in CSFK patients are needed.
Purpose of the Study:
- To evaluate the prognostic value of renal length (RL) > 2 standard deviation scores (SDS) by renal ultrasound (RUS) in identifying CSFK patients at lower risk of KI.
- To estimate the cost savings of an early RUS algorithm (ERUSA) for CSFK follow-up.
Main Methods:
- Retrospective analysis of 56 adult patients with CSFK monitored from infancy.
- Assessment of early RUS (1-3 months) for RL > 2 SDS.
- Definition of KI as hypertension, proteinuria, or declined renal function.
- Cost analysis of ERUSA versus current protocols.
Main Results:
- None of the patients with early RL > 2 SDS developed KI in adulthood.
- Early RL > 2 SDS was predictive of absence of KI at 1-3 months (OR = infinity) and 1 year (OR = 0.13).
- ERUSA demonstrated a cost-sparing effect of 38.6% to 55.3% without missing any KI cases.
Conclusions:
- Renal length > 2 SDS at 1-3 months and 1 year of age predicts a good prognosis in young adulthood for CSFK patients.
- ERUSA offers a cost-effective follow-up strategy for CSFK patients, maintaining crucial long-term monitoring.
Abstract:
We aimed to evaluate the prognostic value of renal length (RL) > 2 standard deviation scores (SDS) measured by renal ultrasound (RUS), across infancy, childhood and adolescence, in identifying which patients with congenital solitary functioning kidney (CSFK) are at lower risk of developing kidney injury (KI). We also estimated the cost saving of integrating the current follow-up protocols with an early RUS algorithm (ERUSA). Fifty-six CSFK adult patients who were 1-3 months old at first observation of undergoing RUS were enrolled. KI was defined by hypertension and/or proteinuria and/or declined renal function. ERUSA was assessed by early (at 1-3 months of life) RUS and was retrospectively tested in our patients. ERUSA establishes that patients with RL > 2SDS at early RUS do not undergo further follow-ups. The others undergo another RUS at 1 year of age along with follow-ups according with current protocols, with the exception of RUS which could be no longer performed. Direct and indirect costs were calculated for each analysed protocol and the cost saving of applying ERUSA was calculated. None of the patients with early RL > 2SDS presented KI in adulthood. A RL > 2SDS was predictive of absence of KI only at 1-3 months (OR = infinity) and 1 year of age (OR = 0.13; 95%CI: 0.03-0.66; p = 0.01). ERUSA provided a total cost-sparing ranging from 38.6% to 55.3% among the analysed follow-up protocols. With ERUSA, no patients developing KI in adulthood were missed. In conclusion, only a RL > 2SDS at 1-3 months and 1 year of age predicted good prognosis in young adulthood. ERUSA can guide a cost-sparing follow-up strategy in CSFK patients while maintaining important long-term information.
Related Concept Videos
Imaging Studies II: Ultrasonography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi III: Medical Management

